208
References
Ammon A, Rumpf KW, Hommerich CP, Behrens-Baumann W, Rüchel R (1992)
Rhinocerebralmucormycosis during deferoxamine therapy. Deutsche medizinischeWochenschrift (1946) 117(38):1434–1438
Balhara M, Chaudhary R, Ruhil S, Singh B, Dahiya N, Parmar VS, Jaiwal PK, Chhillar AK (2016)
Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal
therapy. Expert OpinTher Targets 20(12):1477–1489. Epub 2016 Nov 11
Bertrand S, Larcher G, Landreau A, Richomme P, Duval O, Bouchara JP (2009) Hydroxamate
siderophores of Scedosporiumapiospermum. Biometals 22(6):1019–1029
Blatzer M, Schrettl M, Sarg B, Lindner HH, Pfaller K, Haas H (2011) SidL, an Aspergillus fumigatus transacetylase involved in biosynthesis of the siderophores ferricrocin and hydroxyferricrocin. Appl Environ Microbiol 77(14):4959–4966
Boelaert JR, Vergauwe PL, Verbanck JJ, Segaert MF (1988) The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. Clin nephrol
29(5):261–266
Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, Van Landuyt HW,
Schneider YJ (1993) Mucormycosis during deferoxamine therapy is a siderophore-mediated
infection. In vitro and in vivo animal studies. J Clin Investig 91(5):1979–1986
Brock JH, Williams PH, Liceaga J, Wooldridge KG (1991) Relative availability of transferrinbound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of
Escherichia coli and to other microorganisms. Infect Immun 59(9):3185–3190
Caza M, Kronstad J (2013) Shared and distinct mechanisms of iron acquisition by bacterial and
fungal pathogens of humans. Front Cell Infect Microbiol 3:80
Clarkson AB, Turkel-Parrella D, Williams JH, Chen LC, Gordon T, Merali S (2001) Action of
deferoxamine against Pneumocystis carinii. Antimicrob Agents Chemother 45(12):3560–3565
Dayani PN, Bishop MC, Black K, Zeltzer PM (2004) Desferoxamine (DFO)–mediated iron chelation: rationale for a novel approach to therapy for brain cancer. J Neuro-Oncol 67(3):367–377
De Locht M, Boelaert JR, Schneider YJ (1994) Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 47(10):1843–1850
Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B (2004) Human tear lipocalin exhibits
antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother
48(9):3367–3372
Fratti RA, Belanger PH, Ghannoum MA, Edwards JE, Filler SG (1998) Endothelial cell injury
caused by Candida albicans is dependent on iron. Infect Immun 66(1):191–196
Frederick CB, Szaniszlo PJ, Vickrey PE, Bentley MD, Shive W (1981) Production and isolation
of siderophores from the soil fungus Epicoccumpurpurascens. Biochemistry 20(9):2432–2436
Gostinčar C, Ohm RA, Kogej T, Sonjak S, Turk M, Zajc J, Zalar P, Grube M, Sun H, Han J,
Sharma A (2014) Genome sequencing of four Aureobasidium pullulans varieties: biotechnological potential, stress tolerance, and description of new species. BMC Genomics 15(1):549
Haas H (2014) Fungal siderophore metabolism with a focus on Aspergillus fumigatus. Nat Prod
Rep 31(10):1266–1276
Hatcher HC, Singh RN, Torti FM, Torti SV (2009) Synthetic and natural iron chelators: therapeutic
potential and clinical use. Future Med Chem 1(9):1643–1670
Hazlett L, Suvas S, McClellan S, Ekanayaka S (2016) Challenges of corneal infections. Expert
Rev Ophthalmol 11(4):285–297
Hilty J, George Smulian A, Newman SL (2011) Histoplasma capsulatum utilizes siderophores for
intracellular iron acquisition in macrophages. Med Mycol 49(6):633–642. https://doi.org/10.3
109/13693786.2011.558930. Epub 2011 Feb 22
Hissen AH, Wan AN, Warwas ML, Pinto LJ, Moore MM (2005) The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence.
Infect Immun 73(9):5493–5503
A. Prabahar et al.
References
Ammon A, Rumpf KW, Hommerich CP, Behrens-Baumann W, Rüchel R (1992)
Rhinocerebralmucormycosis during deferoxamine therapy. Deutsche medizinischeWochenschrift (1946) 117(38):1434–1438
Balhara M, Chaudhary R, Ruhil S, Singh B, Dahiya N, Parmar VS, Jaiwal PK, Chhillar AK (2016)
Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal
therapy. Expert OpinTher Targets 20(12):1477–1489. Epub 2016 Nov 11
Bertrand S, Larcher G, Landreau A, Richomme P, Duval O, Bouchara JP (2009) Hydroxamate
siderophores of Scedosporiumapiospermum. Biometals 22(6):1019–1029
Blatzer M, Schrettl M, Sarg B, Lindner HH, Pfaller K, Haas H (2011) SidL, an Aspergillus fumigatus transacetylase involved in biosynthesis of the siderophores ferricrocin and hydroxyferricrocin. Appl Environ Microbiol 77(14):4959–4966
Boelaert JR, Vergauwe PL, Verbanck JJ, Segaert MF (1988) The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. Clin nephrol
29(5):261–266
Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, Van Landuyt HW,
Schneider YJ (1993) Mucormycosis during deferoxamine therapy is a siderophore-mediated
infection. In vitro and in vivo animal studies. J Clin Investig 91(5):1979–1986
Brock JH, Williams PH, Liceaga J, Wooldridge KG (1991) Relative availability of transferrinbound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of
Escherichia coli and to other microorganisms. Infect Immun 59(9):3185–3190
Caza M, Kronstad J (2013) Shared and distinct mechanisms of iron acquisition by bacterial and
fungal pathogens of humans. Front Cell Infect Microbiol 3:80
Clarkson AB, Turkel-Parrella D, Williams JH, Chen LC, Gordon T, Merali S (2001) Action of
deferoxamine against Pneumocystis carinii. Antimicrob Agents Chemother 45(12):3560–3565
Dayani PN, Bishop MC, Black K, Zeltzer PM (2004) Desferoxamine (DFO)–mediated iron chelation: rationale for a novel approach to therapy for brain cancer. J Neuro-Oncol 67(3):367–377
De Locht M, Boelaert JR, Schneider YJ (1994) Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 47(10):1843–1850
Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B (2004) Human tear lipocalin exhibits
antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother
48(9):3367–3372
Fratti RA, Belanger PH, Ghannoum MA, Edwards JE, Filler SG (1998) Endothelial cell injury
caused by Candida albicans is dependent on iron. Infect Immun 66(1):191–196
Frederick CB, Szaniszlo PJ, Vickrey PE, Bentley MD, Shive W (1981) Production and isolation
of siderophores from the soil fungus Epicoccumpurpurascens. Biochemistry 20(9):2432–2436
Gostinčar C, Ohm RA, Kogej T, Sonjak S, Turk M, Zajc J, Zalar P, Grube M, Sun H, Han J,
Sharma A (2014) Genome sequencing of four Aureobasidium pullulans varieties: biotechnological potential, stress tolerance, and description of new species. BMC Genomics 15(1):549
Haas H (2014) Fungal siderophore metabolism with a focus on Aspergillus fumigatus. Nat Prod
Rep 31(10):1266–1276
Hatcher HC, Singh RN, Torti FM, Torti SV (2009) Synthetic and natural iron chelators: therapeutic
potential and clinical use. Future Med Chem 1(9):1643–1670
Hazlett L, Suvas S, McClellan S, Ekanayaka S (2016) Challenges of corneal infections. Expert
Rev Ophthalmol 11(4):285–297
Hilty J, George Smulian A, Newman SL (2011) Histoplasma capsulatum utilizes siderophores for
intracellular iron acquisition in macrophages. Med Mycol 49(6):633–642. https://doi.org/10.3
109/13693786.2011.558930. Epub 2011 Feb 22
Hissen AH, Wan AN, Warwas ML, Pinto LJ, Moore MM (2005) The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence.
Infect Immun 73(9):5493–5503
A. Prabahar et al.